Literature DB >> 10858261

Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase.

R Banerjee1, J Anguita, E Fikrig.   

Abstract

Mice deficient in phox (gp91(phox-/-)) or NOS2 (NOS2(-/-)) were infected with the agent of human granulocytic ehrlichiosis (HGE) to evaluate the importance of these pathways in the eradication of HGE bacteria. NOS2(-/-) mice had delayed clearance of the HGE agent in comparison to control or gp91(phox-/-) mice, suggesting that reactive nitrogen intermediates play a role in the early control of HGE.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10858261      PMCID： PMC101771          DOI： 10.1128/IAI.68.7.4361-4362.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist.

Authors:  D H Walker; J S Dumler
Journal:  Arch Pathol Lab Med       Date:  1997-08       Impact factor: 5.534

2.  Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.

Authors:  C Hölscher; G Köhler; U Müller; H Mossmann; G A Schaub; F Brombacher
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment.

Authors:  P Webster; J W IJdo; L M Chicoine; E Fikrig
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Granulocytic ehrlichiosis in the laboratory mouse.

Authors:  E Hodzic; J W Ijdo; S Feng; P Katavolos; W Sun; C H Maretzki; D Fish; E Fikrig; S R Telford; S W Barthold
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

5.  Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis.

Authors:  M B Klein; J S Miller; C M Nelson; J L Goodman
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

Review 6.  Human ehrlichioses: newly recognized infections transmitted by ticks.

Authors:  J S Dumler; J S Bakken
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

7.  Immunization against the agent of human granulocytic ehrlichiosis in a murine model.

Authors:  W Sun; J W IJdo; S R Telford; E Hodzic; Y Zhang; S W Barthold; E Fikrig
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

8.  Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase.

Authors:  M U Shiloh; J D MacMicking; S Nicholson; J E Brause; S Potter; M Marino; F Fang; M Dinauer; C Nathan
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

9.  Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells.

Authors:  J Mott; R E Barnewall; Y Rikihisa
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

10.  Human granulocytic ehrlichiosis in Bulgaria.

Authors:  I S Christova; J S Dumler
Journal:  Am J Trop Med Hyg       Date:  1999-01       Impact factor: 2.345
View more
  9 in total

Review 1.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Yasunori Ogura; Joao H F Pedra; Koichi S Kobayashi; Richard A Flavell; Erol Fikrig
Journal:  FEMS Immunol Med Microbiol       Date:  2012-07-23

3.  Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes.

Authors:  Roman Reddy Ganta; Melinda J Wilkerson; Chuanmin Cheng; Aaron M Rokey; Stephen K Chapes
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury.

Authors:  Diana G Scorpio; Friederike D von Loewenich; Heike Göbel; Christian Bogdan; J Stephen Dumler
Journal:  Clin Vaccine Immunol       Date:  2006-07

5.  CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains.

Authors:  W C Brown; G H Palmer; H A Lewin; T C McGuire
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 6.  Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence.

Authors:  Wendy C Brown
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-01-04       Impact factor: 2.268

Review 7.  The biological basis of severe outcomes in Anaplasma phagocytophilum infection.

Authors:  J Stephen Dumler
Journal:  FEMS Immunol Med Microbiol       Date:  2011-12-19

8.  Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.

Authors:  Wendy C Brown; Travis C McGuire; Waithaka Mwangi; Kimberly A Kegerreis; Henriette Macmillan; Harris A Lewin; Guy H Palmer
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Differential Susceptibility of Male Versus Female Laboratory Mice to Anaplasma phagocytophilum Infection.

Authors:  Waheeda A Naimi; Ryan S Green; Chelsea L Cockburn; Jason A Carlyon
Journal:  Trop Med Infect Dis       Date:  2018-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.